• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    5/9/25 4:37:58 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    SEC FORM 13F-HR

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 13F

    FORM 13F COVER PAGE

    OMB APPROVAL
    OMB Number: 3235-0006
    Estimated average burden
    hours per response: 23.8

    Report for the Calendar Year or Quarter Ended: 03-31-2025
    Check here if Amendment    Amendment Number:
    This Amendment (Check only one.):    is a restatement.
       adds new holdings entries.
    Institutional Investment Manager Filing this Report:
    Name: Carlyle Group Inc.
    Address: C/O THE CARLYLE GROUP
    1001 PENNSYLVANIA AVENUE, N.W.
    WASHINGTON, DC  20004
    Form 13F File Number: 028-15025
    CRD Number (if applicable): 000111128
    SEC File Number (if applicable): 801-52462

    The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

    Person Signing this Report on Behalf of Reporting Manager:
    Name: Jeffrey W. Ferguson
    Title: General Counsel
    Phone: 202-729-5626
    Signature, Place, and Date of Signing:
    /s/ Jeffrey W. Ferguson Washington,  DC 05-09-2025
    [Signature] [City, State] [Date]
    Explanatory Note 1: AlpInvest Partners B.V. is an indirectly wholly owned investment adviser of The Carlyle Group Inc. However, The Carlyle Group Inc. does not participate in any investment decision-making of AlpInvest Partners B.V. --- Explanatory Note 2: In August 2022, The Carlyle Group Inc. completed its acquisition of the Abingworth group, a life sciences investment firm. As a result of the acquisition, Abingworth LLP became a relying advisor of Carlyle Investment Management L.L.C.
    Report Type (Check only one.):
       13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
       13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
    X 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
    List of Other Managers Reporting for this Manager:
    [If there are no entries in this list, omit this section.]
    Name Form 13F File No. CRD No. (if applicable) SEC File No. (if applicable) CIK
    AlpInvest Partners B.V. 028-15646 000159215 801-72890 0001512910
    Form 13F Summary Page
    Report Summary:
    Number of Other Included Managers: 3
    Form 13F Information Table Entry Total: 23
    Form 13F Information Table Value Total: 3,803,733,001
    (round to nearest dollar)
    List of Other Included Managers:
    Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
    [If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
    No. Name Form 13F File No. CRD No. (if applicable) SEC File No. (if applicable) CIK
    1 Abingworth LLP 028-14285 000163213 802-75741 0001397144
    2 Carlyle Investment Management LLC 028-12429 000111128 801-52462 0001354120
    3 CIM Global, L.L.C. 028-15024 000114795   0001555793

    Get the next $CG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    8/6/2024$46.00 → $44.00Overweight → Neutral
    JP Morgan
    1/19/2024$40.00 → $41.00Buy → Neutral
    Citigroup
    1/4/2024$42.00Market Perform
    TD Cowen
    More analyst ratings

    $CG
    SEC Filings

    See more
    • The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders

      8-K - Carlyle Group Inc. (0001527166) (Filer)

      5/30/25 5:19:46 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

      SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

      5/13/25 11:44:13 AM ET
      $CG
      Investment Managers
      Finance
    • SEC Form 13F-HR filed by The Carlyle Group Inc.

      13F-HR - Carlyle Group Inc. (0001527166) (Filer)

      5/9/25 4:37:58 PM ET
      $CG
      Investment Managers
      Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Carlyle Group Inc. sold $100,225,698 worth of shares (3,671,271 units at $27.30) (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Reporting)

      6/2/25 4:30:39 PM ET
      $CG
      Investment Managers
      Finance
    • General Counsel Ferguson Jeffrey W. was granted 1,368 shares, increasing direct ownership by 0.12% to 1,097,293 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:59 PM ET
      $CG
      Investment Managers
      Finance
    • Chief Executive Officer Schwartz Harvey M was granted 31,709 shares, increasing direct ownership by 0.51% to 6,188,889 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:50 PM ET
      $CG
      Investment Managers
      Finance

    $CG
    Financials

    Live finance-specific insights

    See more
    • Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended March 31, 2025, Declares Second Quarter 2025 Dividend of $0.40 Per Common Share

      NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its first quarter ended March 31, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "Following successful completion of the merger with CSL III at the end of March, CGBD remains focused on driving stable income, consistent credit performance, and disciplined execution of our strategy. Complementing our conservative investing approach, we continue to optimize the capital structure of CGBD, increasing total commitments on our credit facility and exchanging the pre

      5/6/25 4:05:00 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services
    • Carlyle Credit Income Fund Schedules Second Quarter Financial Results and Investor Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, May 20, 2025, for its second quarter of 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, May 21, 2025, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end f

      4/16/25 4:46:22 PM ET
      $CCIF
      $CG
      Finance/Investors Services
      Finance
      Investment Managers
    • Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the First Quarter Ended March 31, 2025

      NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, May 7, 2025 to announce its financial results for the first quarter ended March 31, 2025. The Company will report its quarterly financial results on Tuesday, May 6, 2025. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development company (

      4/15/25 4:25:17 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Carlyle Group upgraded by TD Cowen with a new price target

      TD Cowen upgraded Carlyle Group from Hold to Buy and set a new price target of $56.00

      5/14/25 8:48:54 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group downgraded by Oppenheimer

      Oppenheimer downgraded Carlyle Group from Outperform to Perform

      3/19/25 8:14:15 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group upgraded by Wolfe Research with a new price target

      Wolfe Research upgraded Carlyle Group from Peer Perform to Outperform and set a new price target of $60.00

      1/3/25 7:19:04 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Trucordia to Receive $1.3 Billion Strategic Investment from Carlyle

      Transaction positions company for accelerated growth through improved capital structure and simplified governance LINDON, Utah and NEW YORK, June 4, 2025 /PRNewswire/ -- Trucordia today announced it will receive a $1.3 billion strategic investment from global investment firm Carlyle's Global Credit platform. The transaction will reduce Trucordia's leverage and simplify its governance structure by repurchasing units from existing minority investors. The transaction, which is expected to close this month and values Trucordia at $5.7 billion, provides the company with long-term

      6/4/25 7:00:00 AM ET
      $CG
      Investment Managers
      Finance
    • bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

      New management, led by David Meek, is committed to rapidly scaling access to lifechanging gene therapies Significant capital commitment from Carlyle and SK Capital will enable bluebird to grow and accelerate patient access bluebird will focus on expanding manufacturing capacity and improving the treatment experience for patients and providers bluebird bio (NASDAQ:BLUE) ("bluebird"), a pioneer in gene therapies for severe genetic diseases, today announced the completion of its sale to funds managed by global investment firms Carlyle (NASDAQ:CG) and SK Capital Partners, LP ("SK Capital"). With the closing of the transaction, bluebird's common stock has ceased trading and will no longer

      6/2/25 8:34:00 AM ET
      $BLUE
      $CG
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Investment Managers
      Finance
    • Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

      All conditions of the Offer have been satisfied and the parties expect to consummate the acquisition on June 2, 2025 Carlyle (NASDAQ:CG) ("Carlyle"), SK Capital Partners, LP ("SK Capital") and Beacon Parent Holdings, L.P. ("Parent") today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of bluebird bio, Inc. (NASDAQ:BLUE) ("bluebird") for either (x) $3.00 per share in cash and a contingent value right per share, entitling the holder to a payment of $6.84 in cash per contingent value right ("CVR") if bluebird's current product portfolio achieves $600 million in net sales in any trailing 12-month period prior to or ending on December

      5/30/25 8:30:00 AM ET
      $BLUE
      $CG
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Investment Managers
      Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    See more
    • SoftBank Group to Acquire Ampere Computing

      SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

      3/19/25 7:30:00 PM ET
      $CG
      $ORCL
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

      MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost. "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Boar

      2/4/25 9:58:04 AM ET
      $CG
      Investment Managers
      Finance
    • Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer

      MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025. In this role, Sager will spearhead enterprise-wide change initiatives to help Acentra Health build upon its strong track record of innovation and execution for its clients. She will provide strategic guidance on process improvements to optimize the development and delivery of the company's products, solutions

      1/23/25 9:42:00 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

      11/15/24 5:22:29 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/21/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/15/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance